Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy
Betül Altunay(Universitätsklinikum Aachen), Susanne Lütje(Universitätsklinikum Aachen), Laura Schäfer(Universitätsklinikum Aachen), Matthias Saar(Düsseldorf University Hospital), Agnieszka Morgenroth(RWTH Aachen University), Quim Peña(DWI – Leibniz Institute for Interactive Materials), Twan Lammers(RWTH Aachen University), Felix M. Mottaghy(College Board)
Cited by 6
Related Papers
Tumor targeting via EPR: Strategies to enhance patient responses
|Advanced Drug Delivery Reviews|2018|1.2k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k
Tumour-targeted nanomedicines: principles and practice
|British Journal of Cancer|2008|535
Core-crosslinked polymeric micelles: Principles, preparation, biomedical applications and clinical translation
|Nano Today|2015|499
Toxicity of metal–organic framework nanoparticles: from essential analyses to potential applications
|Chemical Society Reviews|2022|390